Postoperative Opioid-Free Multistep Opiranserin Infusion Versus Fentanyl Patient-Controlled Analgesia After Breast or Minimally Invasive Gynecologic Surgery: A Retrospective Cohort Study
Open Access
- 17 October 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8062
Abstract
Background/Objectives: Women undergoing breast or gynecologic surgery face high postoperative nausea and vomiting (PONV) risk, which often prompts discontinuation of opioid patient-controlled analgesia (PCA). Since anticipated opioid use is an Apfel risk factor, we examined a postoperative opioid-free analgesic regimen using opiranserin, previously evaluated only as an adjunct. Methods: In this single-center retrospective cohort study, 150 women undergoing breast or minimally invasive gynecologic surgery received a multistep opiranserin infusion via a PCA pump without demand boluses (n = 77) or fentanyl demand bolus PCA (n = 73). The opiranserin infusion ended at 10 h; fentanyl PCA remained connected throughout. The primary outcome was resting numeric rating scale (NRS, 0–10) at 24 h, by which time the infusion had been complete for 14–15 h; secondary outcomes were post-anesthesia care unit (PACU) and 6 h NRS, PONV, and early discontinuation. Results: Resting NRS did not differ significantly during the infusion (PACU p = 0.965; 6 h p = 0.675), with a larger difference at 24 h. The adjusted 24 h difference was 0.58 points higher with opiranserin (95% CI, 0.04 to 1.12; p = 0.036) by covariance analysis on pre-treatment covariates and 0.55 (0.02 to 1.09) by inverse-probability-of-treatment weighting; the point estimates were below the minimal clinically important difference of 1 point, but the confidence intervals do not exclude a clinically relevant increase in pain, and the estimate was nonsignificant after adjusting for non-opioid adjuncts (p = 0.177). Moderate or severe pain at 24 h was more frequent with opiranserin (19.5% vs. 8.2%; adjusted odds ratio, 3.76; 95% CI, 1.34 to 11.82). PONV (9.1% vs. 11.0%), rescue analgesia (26.0% vs. 17.8%), and early discontinuation (10.4% vs. 9.6%) were similar. Rescue opioids were available to both groups but used by one fentanyl-group patient and by none receiving opiranserin. Conclusions: The regimen eliminated postoperative opioid exposure, with resting pain scores that differed by less than 1 NRS point on average, although a clinically relevant increase cannot be excluded. With coverage fixed at 10 h, the 24 h difference cannot be separated into a shortfall of the agent and a shortfall of coverage. The anticipated PONV reduction was not observed, possibly in the context of low event rates and routine antiemetic prophylaxis.Keywords
Funding Information
- National Research Foundation of Korea (RS-2025-24535372)
This publication has 26 references indexed in Scilit:
- A core outcome set of measurement instruments for assessing effectiveness and efficacy of perioperative pain management: results of the international IMI-PainCare PROMPT Delphi consensus processBritish Journal of Anaesthesia, 2025
- Reduction of postoperative pain and opioid consumption by VVZ-149, first-in-class analgesic molecule: A confirmatory phase 3 trial of laparoscopic colectomyJournal of Clinical Anesthesia, 2024
- Non-opioid analgesics for the prevention of chronic postsurgical pain: a systematic review and network meta-analysisBritish Journal of Anaesthesia, 2023
- Exploratory study of VVZ-149, a novel analgesic molecule, in the affective component of acute postoperative pain after laparoscopic colorectal surgeryJournal of Clinical Anesthesia, 2022
- Preventing opioid prescription after major surgery: a scoping review of opioid-free analgesiaBritish Journal of Anaesthesia, 2019
- The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuseBritish Journal of Anaesthesia, 2019
- Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative PeriodJAMA Internal Medicine, 2016
- Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative CouncilThe Journal of Pain, 2016
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- Anaesthesia, surgery, and challenges in postoperative recoveryThe Lancet, 2003